The cost-effectiveness and budget impact of zoledronic acid as adjuvant therapy in postmenopausal women with early breast cancer.

Saved in:
Bibliographic Details
Title: The cost-effectiveness and budget impact of zoledronic acid as adjuvant therapy in postmenopausal women with early breast cancer.
Alternate Title: 唑来膦酸用于绝经后早期乳腺癌患者辅助治疗的成本效果与预算影响分析
Authors: Zhu, Yixiao1, Wu, Wenhua2, Lin, Li1, Zhang, Lirong1, Cai, Jiaqing2, Sun, Hong2 sunhong7777@fjmu.edu.cn, Wei, Xiaoxia2 xxwei0321@outlook.com
Source: Journal of Chinese Pharmaceutical Sciences. Mar2026, Vol. 35 Issue 3, p292-314. 23p.
Database: Academic Search Ultimate
Description
ISSN:10031057
DOI:10.5246/jcps.2026.03.020